DroneX 2026: Scaling Drone Manufacturing Beyond the Battlefield
9 October 2026.DroneX 2026 highlights mounting pressures on drone manufacturing and procurement
Battlefield lessons, modular systmens and the power bottleneck; News and coverage from the event.
The race to electrify and next gen mobility; our coverage on the latest developments shaping automotive strategy.
DroneX 2026 highlights mounting pressures on drone manufacturing and procurement
CPHI Milan examines what turns pharmaceutical innovation into commercial scale
The global sonar systems market is valued at US$4.59bn in 2027
CPHI Milan tests manufacturing capability, execution, validation and proven performance
CPHI Milan highlights specialist capacity, resilient supply and scalable AI
US defence links autonomy, resilience and procurement in major reforms
Ukraine war innovations, maturing power solutions and regulatory changes shape DroneX 2026.
CPHI Milan opens next week with manufacturing under growing scrutiny across the pharmaceutical industry
The global Antibody Drug Conjugates market is projected to grow at a CAGR of 11.8% by 2036
Ukraine’s combat-proven systems were a strong presence at DroneX 2026
High on the list is what is happening in the powering space
Biologics outsourcing and demand for specialist manufacturing capacity are driving 9.7% CAGR through 2036.
The Peptide Contract Manufacturing market is projected to grow at a CAGR of 12.7% by 2036
The global Antibody Drug Conjugates Contract Manufacturing market is projected to grow at a CAGR of 11.4% by 2036
Britain reshapes battlefield reconnaissance with AR5 and smaller tactical drones
The global Macular Degeneration (AMD) and Other Retinal Diseases Drugs market is projected to grow at a CAGR of 9.0% by 2036
The mRNA Contract Manufacturing market is projected to grow at a CAGR of 11.3% by 2036
Clinical trials are getting harder to run as complexity increases
The market is valued at US$652.89 billion in 2026 and is projected to reach US$2,103.43 billion by 2036, expanding at a 12.4% CAGR
Visiongain has launched an independent primary research study examining the capabilities, requirements and constraints shaping US drone manufacturing.